1. Home
  2. WMK vs SUPN Comparison

WMK vs SUPN Comparison

Compare WMK & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WMK
  • SUPN
  • Stock Information
  • Founded
  • WMK 1912
  • SUPN 2005
  • Country
  • WMK United States
  • SUPN United States
  • Employees
  • WMK N/A
  • SUPN N/A
  • Industry
  • WMK Food Chains
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • WMK Consumer Staples
  • SUPN Health Care
  • Exchange
  • WMK Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • WMK 1.9B
  • SUPN 2.0B
  • IPO Year
  • WMK N/A
  • SUPN 2012
  • Fundamental
  • Price
  • WMK $73.67
  • SUPN $44.88
  • Analyst Decision
  • WMK
  • SUPN Buy
  • Analyst Count
  • WMK 0
  • SUPN 2
  • Target Price
  • WMK N/A
  • SUPN $41.00
  • AVG Volume (30 Days)
  • WMK 135.1K
  • SUPN 1.1M
  • Earning Date
  • WMK 08-06-2025
  • SUPN 08-05-2025
  • Dividend Yield
  • WMK 1.90%
  • SUPN N/A
  • EPS Growth
  • WMK 15.99
  • SUPN 1411.53
  • EPS
  • WMK 4.02
  • SUPN 1.14
  • Revenue
  • WMK $4,842,632,000.00
  • SUPN $665,125,000.00
  • Revenue This Year
  • WMK N/A
  • SUPN N/A
  • Revenue Next Year
  • WMK N/A
  • SUPN $15.74
  • P/E Ratio
  • WMK $18.31
  • SUPN $39.23
  • Revenue Growth
  • WMK 1.75
  • SUPN 5.55
  • 52 Week Low
  • WMK $62.25
  • SUPN $29.16
  • 52 Week High
  • WMK $90.23
  • SUPN $45.01
  • Technical
  • Relative Strength Index (RSI)
  • WMK 53.93
  • SUPN 76.97
  • Support Level
  • WMK $70.05
  • SUPN $41.78
  • Resistance Level
  • WMK $72.38
  • SUPN $43.73
  • Average True Range (ATR)
  • WMK 2.20
  • SUPN 1.65
  • MACD
  • WMK 0.25
  • SUPN 0.22
  • Stochastic Oscillator
  • WMK 86.45
  • SUPN 98.48

About WMK Weis Markets Inc.

Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: